Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on April 27, 2015, by Cellectis S.A., a foreign private issuer, serves as a notice regarding the Company's upcoming Combined Ordinary and Extraordinary General Meeting. The meeting is scheduled for May 18, 2015, at 2:30 p.m. Paris time, located at 11 rue Watt, 75013 Paris, France.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. While a "Summary Presentation for the Year Ending December 31, 2014" is listed as Exhibit 99.4, the numerical data from that presentation is not included in the body of this report.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The document focuses exclusively on the procedural announcement of the shareholder meeting and the incorporation of related meeting documents by reference.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risk factors, or contingencies are not disclosed in the text of this filing. The document acts as a procedural notice to inform shareholders and depositary holders of the meeting date, location, and agenda.
Key Facts for Investor Verification
- Verify the date and location of the Combined Ordinary and Extraordinary General Meeting: May 18, 2015, in Paris, France.
- Review the attached exhibits (99.1 through 99.6) for the specific agenda, resolutions, and voting instructions for American Depositary Share holders.
- Consult the separate "Summary Presentation for the Year Ending December 31, 2014" (Exhibit 99.4) for actual financial performance data, as it is not summarized in this filing text.
- Confirm voting procedures and deadlines for American Depositary Share holders as outlined in the attached voting instruction documents.